Rediff-TV 📺

This browser does not support the video element.

Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.

2 days ago

Duration: 0h 4m 51s

Abbott Bets On Semaglutide Boom

Name: Abbott Bets On Semaglutide Boom
Uploaded: 2026-02-28T06:23:10+00:00
Duration: 4 min 51 s
Channel: Rediff Video Desk
Description: Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

Uploaded by: Rediff Video Desk on Sat, 28 Feb 2026 11:53:10 +0530

Views: 42

Tags: India, Novo Nordisk, Abbott, Ozempic, Emcure Pharma, Semaglutide Boom, Wegovy, Mounjaro, Extensior, Lilly